Adrian Rawcliffe Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Adrian Rawcliffe.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Adrian Rawcliffe. Adrian Rawcliffe is a CEO and CFO in Adaptimmune Therapeutics PLC ($ADAP) and an Chief Executive Officer in Adaptimmune Therapeutics PLC ($ADAP) and a Chief Financial Officer in Adaptimmune Therapeutics PLC ($ADAP) and a Director in Wave Life Sciences Ltd. ($WVE).
Address: 980 GREAT WEST ROAD BRENTFORD, MIDDLESEX, ENGLAND TW9 9GS
Companies in which Adrian Rawcliffe is an Insider
Adaptimmune Therapeutics PLC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Adrian Rawcliffe: Chief Executive Officer, CEO and CFO, Chief Financial Officer
Holdings: 3,058 shares
Current Value: $13,853
Latest Transaction: Jun 28 2021
$ADAP Market Capitalization: $321.36M
$ADAP Previous Close: $4.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Wave Life Sciences Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Adrian Rawcliffe: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Aug 20 2020
$WVE Market Capitalization: $681.95M
$WVE Previous Close: $28.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Adrian Rawcliffe
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 28 2021 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Executive Off ... | Sell | S | 4.37 | 2,794 | 12,210 | 3,058 | 5.9 K to 3.1 K (-47.74 %) |
| Jan 19 2021 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Executive Off ... | Sell | S | 5.67 | 9,879 | 56,009 | 13,529 | 23.4 K to 13.5 K (-42.20 %) |
| Jan 12 2021 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Executive Off ... | Sell | S | 6.15 | 2,707 | 16,654 | 3,695 | 6.4 K to 3.7 K (-42.28 %) |
| Jan 11 2021 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Executive Off ... | Option Exercise | A | 0.00 | 728,160 | 1,019 | 728,160 | |
| Jan 11 2021 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Executive Off ... | Option Exercise | A | 1.03 | 3,260,400 | 3,358,212 | 3,260,400 | |
| Jan 05 2021 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Executive Off ... | Sell | S | 5.33 | 4,967 | 26,464 | 6,737 | 11.7 K to 6.7 K (-42.44 %) |
| Sep 02 2020 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Executive Off ... | Sell | S | 8.51 | 2,776 | 23,637 | 3,076 | 5.9 K to 3.1 K (-47.44 %) |